Ciliary Sulcus Implantation of Ahmed Glaucoma Valve in Patients with Corneal Decompensation Risk
INTRODUCTION[|]The goal of this study was to examine the safety and efficacy of ciliary sulcus implantation of the Ahmed glaucoma valve (AGV; New World Medical, Inc., Rancho Cucamonga, CA, USA) in patients with a risk of corneal decompensation.[¤]METHODS[|]Patients with a corneal decompensation risk...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2019-08-01
|
Series: | Beyoglu Eye Journal |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-00710 |
id |
doaj-4cf7cab1c88a4878953dea2e15895202 |
---|---|
record_format |
Article |
spelling |
doaj-4cf7cab1c88a4878953dea2e158952022021-01-24T17:50:15ZengKARE PublishingBeyoglu Eye Journal2587-03942019-08-014211511910.14744/bej.2019.00710BEJ-00710Ciliary Sulcus Implantation of Ahmed Glaucoma Valve in Patients with Corneal Decompensation RiskSerhat Imamoglu0Nimet Yesim Ercalik1Buse Guneri Beser2Nimet Burcu Celik3Department of Ophthalmology, Haydarpasa Numune Training and Research Hospital, Istanbul, TurkeyDepartment of Ophthalmology, Haydarpasa Numune Training and Research Hospital, Istanbul, TurkeyDepartment of Ophthalmology, Haydarpasa Numune Training and Research Hospital, Istanbul, TurkeyDepartment of Ophthalmology, Haydarpasa Numune Training and Research Hospital, Istanbul, TurkeyINTRODUCTION[|]The goal of this study was to examine the safety and efficacy of ciliary sulcus implantation of the Ahmed glaucoma valve (AGV; New World Medical, Inc., Rancho Cucamonga, CA, USA) in patients with a risk of corneal decompensation.[¤]METHODS[|]Patients with a corneal decompensation risk who underwent AGV implantation at a single institution were included in this retrospective study. The patients' preoperative intraocular pressure (IOP), best corrected visual acuity (BCVA), and the number of anti-glaucomatous eye drop medications used was compared with postoperative values. The success criteria were defined as a postoperative IOP of 5 to 21 mmHg and no loss of light perception.[¤]RESULTS[|]Twenty-three eyes of 23 (16 male, 7 female) patients were included in the study. The mean age of the patients was 64.6+-14.6 years and the mean follow-up period was 15.8+-8.3 months. The preoperative mean IOP was reduced from 33.6+-9.1 mmHg to 16.9+-5.1 mmHg at the last follow-up (p=0.000). The mean preoperative number of anti-glaucomatous eye drop medications used was 3.5+-1.3. Postoperatively the mean was 1.7+-1.4 at the last follow-up (p=0.000). The rate of total success was determined to be 78%. The postoperative mean BCVA did not change significantly. One patient lost light perception. A decrease in corneal clarity was observed in only 1 patient (4.3%). The postoperative complications observed were: bleb encapsulation (43%), hyphema (39%), tube occlusion (13%), choroidal detachment (8.7%), decompression retinopathy (8.7%), and corneal decompensation (4.3%).[¤]DISCUSSION AND CONCLUSION[|]Ciliary sulcus implantation of an AGV was effective, both in terms of IOP and the decrease in anti-glaucomatous drug use in the short term. This technique may be a good choice in patients with a corneal decompensation risk due to the posterior chamber implantation.[¤]https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-00710ahmed glaucoma valveciliary sulcuscorneal decompensation. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Serhat Imamoglu Nimet Yesim Ercalik Buse Guneri Beser Nimet Burcu Celik |
spellingShingle |
Serhat Imamoglu Nimet Yesim Ercalik Buse Guneri Beser Nimet Burcu Celik Ciliary Sulcus Implantation of Ahmed Glaucoma Valve in Patients with Corneal Decompensation Risk Beyoglu Eye Journal ahmed glaucoma valve ciliary sulcus corneal decompensation. |
author_facet |
Serhat Imamoglu Nimet Yesim Ercalik Buse Guneri Beser Nimet Burcu Celik |
author_sort |
Serhat Imamoglu |
title |
Ciliary Sulcus Implantation of Ahmed Glaucoma Valve in Patients with Corneal Decompensation Risk |
title_short |
Ciliary Sulcus Implantation of Ahmed Glaucoma Valve in Patients with Corneal Decompensation Risk |
title_full |
Ciliary Sulcus Implantation of Ahmed Glaucoma Valve in Patients with Corneal Decompensation Risk |
title_fullStr |
Ciliary Sulcus Implantation of Ahmed Glaucoma Valve in Patients with Corneal Decompensation Risk |
title_full_unstemmed |
Ciliary Sulcus Implantation of Ahmed Glaucoma Valve in Patients with Corneal Decompensation Risk |
title_sort |
ciliary sulcus implantation of ahmed glaucoma valve in patients with corneal decompensation risk |
publisher |
KARE Publishing |
series |
Beyoglu Eye Journal |
issn |
2587-0394 |
publishDate |
2019-08-01 |
description |
INTRODUCTION[|]The goal of this study was to examine the safety and efficacy of ciliary sulcus implantation of the Ahmed glaucoma valve (AGV; New World Medical, Inc., Rancho Cucamonga, CA, USA) in patients with a risk of corneal decompensation.[¤]METHODS[|]Patients with a corneal decompensation risk who underwent AGV implantation at a single institution were included in this retrospective study. The patients' preoperative intraocular pressure (IOP), best corrected visual acuity (BCVA), and the number of anti-glaucomatous eye drop medications used was compared with postoperative values. The success criteria were defined as a postoperative IOP of 5 to 21 mmHg and no loss of light perception.[¤]RESULTS[|]Twenty-three eyes of 23 (16 male, 7 female) patients were included in the study. The mean age of the patients was 64.6+-14.6 years and the mean follow-up period was 15.8+-8.3 months. The preoperative mean IOP was reduced from 33.6+-9.1 mmHg to 16.9+-5.1 mmHg at the last follow-up (p=0.000). The mean preoperative number of anti-glaucomatous eye drop medications used was 3.5+-1.3. Postoperatively the mean was 1.7+-1.4 at the last follow-up (p=0.000). The rate of total success was determined to be 78%. The postoperative mean BCVA did not change significantly. One patient lost light perception. A decrease in corneal clarity was observed in only 1 patient (4.3%). The postoperative complications observed were: bleb encapsulation (43%), hyphema (39%), tube occlusion (13%), choroidal detachment (8.7%), decompression retinopathy (8.7%), and corneal decompensation (4.3%).[¤]DISCUSSION AND CONCLUSION[|]Ciliary sulcus implantation of an AGV was effective, both in terms of IOP and the decrease in anti-glaucomatous drug use in the short term. This technique may be a good choice in patients with a corneal decompensation risk due to the posterior chamber implantation.[¤] |
topic |
ahmed glaucoma valve ciliary sulcus corneal decompensation. |
url |
https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-00710 |
work_keys_str_mv |
AT serhatimamoglu ciliarysulcusimplantationofahmedglaucomavalveinpatientswithcornealdecompensationrisk AT nimetyesimercalik ciliarysulcusimplantationofahmedglaucomavalveinpatientswithcornealdecompensationrisk AT buseguneribeser ciliarysulcusimplantationofahmedglaucomavalveinpatientswithcornealdecompensationrisk AT nimetburcucelik ciliarysulcusimplantationofahmedglaucomavalveinpatientswithcornealdecompensationrisk |
_version_ |
1724325236084572160 |